Further experiments are necessary to establish if activation of NF-κB pro-apoptotic ability, via p-NF-κB/HDAC1 complex formation, plays a role in bortezomib/CX-4945 cytotoxicity in all B-ALL or only in some subsets of B-ALL. The gene discussed is NFKB1; the disease is acute lymphoblastic leukemia.